Norris Medicines Ltd.

NORRIS

₹15.22

-0.78% (-0.12)

Market Cap

₹15 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

15.00 Cr

Prom Holding

34.00 %

ROE (%)

8.32

ROCE (%)

-26.80

Div Yield (%)

Sales

6.55 Cr

OPM (%)

-3.10 %

Debt to Equity

-1.45

Edit Ratio's

About

Norris Medicines Ltd. is one of the leading Indian manufacturers of Injections and Medicinal f… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

3 Yes

Positive for this company

2 Neutral

Neutral for this company

11 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Financial leverage has increased roe over 10 years
Capex vs ROCE

Roce of the company has decreased even without significant capex
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Norris Medicines Ltd. Business

What does Norris Medicines do?

Norris Medicines Ltd. is a prominent Indian producer specializing in Injections and Medicinal formulations.

Who are the competitors of Norris Medicines?

Norris Medicines major competitors are Emmessar Biotech&Nut, Saroja Pharma Ind, Link Pharma Chem, Cian Healthcare, Unjha Formulations, Parmax Pharma, Beryl Drugs.
Market Cap of Norris Medicines is ₹15 Crs.
While the median market cap of its peers are ₹15 Crs.

Is Norris Medicines financially stable compared to its competitors?

Norris Medicines seems to be less financially stable compared to its competitors.
Altman Z score of Norris Medicines is -2.48 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Norris Medicines Ltd.

Norris Medicines Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

3 Yes

2 Neutral

11 No

1 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Pledge

Promoter Holding

Depreciation Effect

Retail Holding

Revenue Recognition

Price & Performance

ROE

Capex vs ROCE

Debt

Share price

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Balance Sheet Strength

Current vs Historic Valuation

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

FAQs on Norris Medicines Ltd. Business

What does Norris Medicines do?

Who are the competitors of Norris Medicines?

Is Norris Medicines financially stable compared to its competitors?

Company Filing

Discussions & Analysis

SIGN UP FOR FREE